Molecular Data
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Molecular Data's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 42% to $7,596,412,000. Profit margin reached -4%. Total operating expenses were $321,358,000.

Profit Margin

Molecular Data Inc. (NASDAQ:MKD): Profit margin
2016 3.20B -113.93M -3.55%
2017 4.20B -107.80M -2.57%
2018 9.05B -254.63M -2.81%
2019 13.20B -193.54M -1.47%
2020 7.59B -328.03M -4.32%

MKD Income Statement (2016 – 2020)

2020 2019 2018 2017 2016
Revenue
Revenue
7.59B13.20B9.05B4.20B3.20B
Cost of revenue
7.60B13.10B8.97B4.15B3.17B
Gross profit
-10.19M100.77M80.16M50.23M26.11M
Operating exp.
Research and development
35.21M45.03M36.88M18.60M20.06M
Selling and marketing
67.01M108.85M103.29M64.96M59.16M
Total operating expenses
321.35M292.98M315.96M139.96M131.89M
Operating income
-331.55M-192.21M-235.79M-91.18M-105.77M
Other income (expenses), net
-136.78M-871K-18.84M-16.62M-8.16M
Income before tax
-325.58M-193.08M-254.63M-107.80M-113.93M
Income tax expense
2.45M465K202K202K273K
Net income
-328.03M-193.54M-254.63M-107.80M-113.93M
Earnings per share
Basic EPS
-2.62-1.87-2.21-0.94-0.99
Diluted EPS
-2.62-1.87-2.21-0.94-0.99
Data sourceData source